Opendata, web and dolomites

Signalling-in-NODs

Investigation of the role and mechanism of action of NOD2-mediated isoform selective PI3K signalling in gut immunity and inflammation

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Signalling-in-NODs project word cloud

Explore the words cloud of the Signalling-in-NODs project. It provides you a very rough idea of what is the project "Signalling-in-NODs" about.

components    mechanism    family    plan    innate    disease    kinases    nod    orchestrating    discovered    phenomena    isoforms    either    strategies    domain    biological    driving    peptides    host    deleterious    vivo    functions    societies    caused    messengers    mutations    initiated    therapeutic    proteins    isoform    prr    protection    models    phosphoinositide    inflammation    phenomenon    nlr    variants    immunology    mechanisms    pathology    regulate    autophagy    p110    elucidate    receptor    discover    protective    ibd    nucleotide    alongside    signaling    pi3ks    generate    recognition    western    molecular    inflammatory    cell    unmet    bowel    pharmacological    underlying    lipid    integrate    oligomerization    dendritic    gut    evolutionarily    mice    pi3k    microbiology    convey    delta    immunity    linked    intrinsic    biology    mediated    anti    tolerance    little    dysregulated    susceptibility    conserved    roles    animal    genetic    immune    made    microbial    regulating    despite    unravel    programs    gene    intestinal    pathogen    nod2    chronic    action    molecules    single    risk   

Project "Signalling-in-NODs" data sheet

The following table provides information about the project.

Coordinator
QUEEN MARY UNIVERSITY OF LONDON 

Organization address
address: 327 MILE END ROAD
city: LONDON
postcode: E1 4NS
website: http://www.qmul.ac.uk

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Total cost 195˙454 €
 EC max contribution 195˙454 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2016
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2017
 Duration (year-month-day) from 2017-05-01   to  2019-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    QUEEN MARY UNIVERSITY OF LONDON UK (LONDON) coordinator 195˙454.00

Map

 Project objective

Inflammatory bowel disease (IBD) is a complex chronic pathology in western societies. There is an unmet need for new therapeutic strategies which can only be achieved through a better understanding of the molecular mechanisms of host immunity. It is established that dysregulated host innate immune recognition either caused by genetic risk variants in pathogen recognition receptor (PRR) molecules or microbial factors is commonly associated with IBD. A unique PRR family member, Nucleotide oligomerization domain (NOD)2 programs gut immunity and protection through autophagy process initiated by the recognition of microbial peptides. Deleterious mutations in NOD2 and autophagy-associated proteins are linked to IBD susceptibility. Despite the advances made in understanding of the mechanisms underlying NOD2 biology, particularly that of autophagy, very little is known about the cell signaling components and their mechanism regulating autophagy under NOD2 pathway. Recently, I discovered that a single Phosphoinositide 3-kinases (PI3K) isoform p110δ is integrated in NOD2 mediated autophagy process. PI3Ks are an evolutionarily conserved family of signaling molecules that integrate PRR signaling. PI3Ks generate lipid second messengers and regulate mediated immune responses. I now propose to unravel key biological phenomenon by which p110δ PI3K convey host protective functions through NOD2-mediated autophagy, ensuring the gut immunity and tolerance. The aims are to (1) Determine the dendritic cell-intrinsic role and mechanism(s) of action of PI3K isoforms in orchestrating anti-inflammatory processes under NOD2-mediated autophagy. (2) Discover the roles of PI3K isoforms in NLR-mediated intestinal immunity using isoform specific PI3K gene-targeted mice alongside with pharmacological targeting strategies in vivo. My plan is integrated with animal models, immunology, cell biology, microbiology and in vivo inflammation studies to elucidate key biological phenomena driving IBD.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SIGNALLING-IN-NODS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SIGNALLING-IN-NODS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

HOCOM (2019)

A Transparent Hole Conductor by Combinatorial Techniques for Next-Generation Energy Conversion Devices

Read More  

INFANTPATTERNS (2019)

Development of kinematic and muscle patterns in preterm infants

Read More  

signalling dynamics (2020)

Bridging biophysics and cell biology: The role of G protein-coupled receptor conformations in signalling

Read More